Search clinical trials for: Tamiflu®

Total 13768 results

National Institute of Allergy and Infectious Diseases...

Completed

Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza

Influenza

United States, Canada
Genuine Research Center, Egypt
Pharmacare PLC, Palestine

Completed

A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)

Healthy

Egypt
National Institute for Public Health and the Environment...
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes (PEPpIE)

Influenza

Netherlands
Hoffmann-La Roche

Completed

A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

Drug Therapy, Combination

United Kingdom
Adamas Pharmaceuticals, Inc.

Completed

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects (PO206)

Influenza

United States, Australia, Canada, Netherlands, Singapore
Chinese University of Hong Kong
Food and Health Bureau, Hong Kong; Hospital Authority

Terminated

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Influenza | Upper Respiratory Tract Infection

China, Hong Kong
Hoffmann-La Roche

Completed

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Influenza

Italy, United States, Spain, Hungary, France, Lithuania, Romania, Poland, Denmark
Unity Health Toronto
University of Toronto; Li Ka Shing Knowledge Institute

Unknown

Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Immune Thrombocytopenia

Canada
Pharmahungary Group
Hoffmann-La Roche

Completed

Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation

Influenza

Hungary
The Affiliated Hospital of Qingdao University

Completed

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Healthy Subjects

China
Shionogi

Completed

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2)

Influenza
Shionogi

Completed

A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza (CAPSTONE 1)

Influenza
Hoffmann-La Roche

Completed

Influenza Resistance Information Study (IRIS)

Influenza

Australia, Hong Kong, United States, France, Germany, Netherlands, Norway, Poland
Hoffmann-La Roche

Terminated

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Influenza

United States, Israel
Hoffmann-La Roche

Terminated

A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

Influenza

Italy
Hoffmann-La Roche

Completed

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Influenza

United States, Lebanon, Israel
Trial Management Group Inc.
Hoffmann-La Roche

Terminated

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS) (Access)

Influenza

Canada
Hoffmann-La Roche

Terminated

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain

Influenza

United States
University of Manitoba
Hoffmann-La Roche

Terminated

Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU (ROSII)

Influenza A Virus

Canada
University of Oxford
South East Asia Infectious Disease Clinical Research Network

Completed

Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand

Metabolic Disease

Thailand
Trial Management Group Inc.
Hoffmann-La Roche

Completed

Effect of Oseltamivir on Cognitive Function in Subjects With Influenza (FOCUS)

Influenza

Canada
Hoffmann-La Roche

Completed

A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza

Influenza

Brazil
National Institute of Allergy and Infectious Diseases...
University of Oxford; Wellcome Trust; World Health Organization

Completed

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Influenza | Avian Influenza | Severe Influenza

Singapore, Thailand, Vietnam
University of Oxford

Withdrawn

Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One

Influenza

Thailand
Hoffmann-La Roche

Completed

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Influenza

United States, Spain, Belgium, Canada, Colombia, Germany, Israel, Poland, Brazil, Chile, Finland, Greece, Italy, Mexico, South Africa
Hoffmann-La Roche

Completed

A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)

End Stage Renal Disease

New Zealand
National Institute of Allergy and Infectious Diseases...

Withdrawn

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Influenza
Materia Medica Holding

Completed

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Influenza

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

Influenza

Russian Federation
Hoffmann-La Roche

Completed

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Influenza

United States, Denmark, Canada
Manjunath Prakash Pai
Hoffmann-La Roche

Completed

Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects

Obesity

United States
University of Louisville
Centers for Disease Control and Prevention

Completed

Rapid Empiric Treatment With Oseltamivir Study (RETOS) (RETOS)

Pneumonia | Influenza

United States
Marshfield Clinic Research Foundation
Centers for Disease Control and Prevention

Completed

Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza

Influenza

United States
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants

Influenza

Belgium, Israel, Italy, Spain, United States, Germany, Canada, France, Estonia, Poland, Hungary, Lithuania, United Kingdom, Czech Republic
University of Manitoba
Hoffmann-La Roche

Withdrawn

Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

Influenza A Virus Infection | Influenza B Virus Infection

Canada
Hoffmann-La Roche

Completed

A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance

Healthy Volunteer

New Zealand
Hoffmann-La Roche

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Participants

Healthy Volunteer

United States
Genentech, Inc.

Completed

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

Influenza

Spain, United Kingdom, Korea, Republic of, Belgium, Czechia, Canada, Netherlands, Hong Kong, New Zealand, Peru, Germany, France, Israel, Hungary, South Africa, Sweden, Mexico, Taiwan, Brazil, Bulgaria, Chile, Italy, Poland, Russian Federation and more
Hoffmann-La Roche

Completed

A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection

Influenza

Belgium, Poland, France, Germany, Italy, Spain
Hospital District of Southwestern Finland
Hoffmann-La Roche

Completed

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

Influenza

Finland
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Influenza, Human

United States, Spain, Belgium, Poland, Germany, United Kingdom, Chile, Estonia, Hungary, Italy, France, South Africa, Mexico, Israel, Brazil, Guatemala, Czechia, Lithuania, Argentina, Bulgaria, Canada, Colombia, Latvia, Romania, Switzer... and more
Genentech, Inc.

Completed

A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

Healthy Volunteer

United Kingdom
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults

Virus Diseases | Influenza

Thailand
Tongji Hospital

Recruiting

Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients

ST Elevation Myocardial Infarction | STEMI

China
University of Pittsburgh
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Withdrawn

A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy

Pregnancy | Influenza

United States
Centers for Disease Control and Prevention
Universidad del Valle, Guatemala; Hospital Nacional San Juan de Dios de Santa... and other collaborators

Terminated

Panama and El Salvador Children's Oseltamivir Study (PECOS)

Influenza | Human Influenza

Panama, El Salvador
Weill Medical College of Cornell University
Genentech, Inc.

Recruiting

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

Influenza

United States
Seoul National University Hospital

Completed

A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir (CES1)

Healthy

Korea, Republic of
MedImmune LLC

Withdrawn

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

Influenza - Type A Strains
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403, HGP0919

Healthy

Korea, Republic of

Search clinical trials for: Tamiflu®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations